Page last updated: 2024-09-04

moxifloxacin and Precordial Catch

moxifloxacin has been researched along with Precordial Catch in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Chen, F; Chen, Y; Fang, Q; Hu, S; Jiang, J; Liang, T; Lu, S; Sheng, J; Wei, N; Wu, L; Zheng, S; Zhou, J1
Busch, W; Lorenz, J; Thate-Waschke, IM1

Other Studies

2 other study(ies) available for moxifloxacin and Precordial Catch

ArticleYear
First report of manic-like symptoms in a COVID-19 patient with no previous history of a psychiatric disorder.
    Journal of affective disorders, 2020, 12-01, Volume: 277

    Topics: Antibodies, Viral; Antipsychotic Agents; Antiviral Agents; Betacoronavirus; Bipolar Disorder; Brain; Chest Pain; China; Clinical Laboratory Techniques; Cobicistat; Coronavirus Infections; COVID-19; COVID-19 Testing; Darunavir; Dyspnea; Fever; Glucocorticoids; Humans; Indoles; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Moxifloxacin; Olanzapine; Pandemics; Pharyngitis; Pneumonia, Viral; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2

2020
[Therapy study of acute exacerbated chronic bronchitis. Quinolone rapidly improves cough and chest pain. BRONCHIMOX Study Group].
    MMW Fortschritte der Medizin, 2000, Jun-01, Volume: 142, Issue:22

    Topics: Anti-Infective Agents; Aza Compounds; Bronchitis; Chest Pain; Chronic Disease; Cough; Drug Administration Schedule; Fluoroquinolones; Humans; Moxifloxacin; Quinolines; Treatment Outcome

2000